A Master Of Firsts: Pascal Touchon On Atara Bio And The Maturing Cell Therapy Ecosystem

 
• By David Wild

Having led the way to regulatory approval for Kymriah and now Ebvallo, Atara CEO Pascal Touchon reflects on the evolution of cell therapy and what his company is doing differently.

Atara's Platform Has The Epstein-Barr Virus At Its Core • Source: Shutterstock

More from Archive

More from In Vivo